首页> 外国专利> NEW USE FOR MANNOSE FOR INCREASING TREG CELL NUMBER AND FOXP3 FACTOR EXPRESSION LEVEL THEREOF

NEW USE FOR MANNOSE FOR INCREASING TREG CELL NUMBER AND FOXP3 FACTOR EXPRESSION LEVEL THEREOF

机译:新的用法,用于增加TREG细胞数和FOXP3因子表达水平

摘要

The present application relates to the fields of medicine, food, health products and cosmetics, and specifically to the use of mannose. The present application relates to the use of mannose in the preparation of a drug, a food, a health product or a cosmetic product for treating autoimmune diseases, further relates to the use of mannose in the preparation of a drug, a food, a health product or a cosmetic product for maintaining immune homeostasis, and further relates to the use of mannose in the preparation of a drug, a food, a health product or a cosmetic product for increasing regulatory T (Treg) cell levels. Research has found that when Treg cell levels are imbalanced, mannose has certain effects on adjusting Treg cell levels such that the same may be used for drugs, foods, health products or cosmetic products for Treg cell level imbalance, and has the effects of treatment and adjuvant treatment on autoimmune diseases which are triggered by Treg cell level imbalance and immune homeostasis imbalance which is triggered by Treg cell level imbalance.
机译:本申请涉及医药,食品,保健品和化妆品领域,尤其涉及甘露糖的用途。本发明涉及甘露糖在制备用于治疗自身免疫性疾病的药物,食品,保健品或化妆品中的用途,还涉及甘露糖在制备药物,食品,保健品中的用途。产品或用于维持免疫稳态的化妆品,还涉及甘露糖在制备药物,食品,保健品或化妆品中用于增加调节性T(Treg)细胞水平的用途。研究发现,当Treg细胞水平失衡时,甘露糖对调节Treg细胞水平具有一定作用,因此可将其用于治疗Treg细胞水平失衡的药物,食品,保健品或化妆品中,并具有治疗和治疗作用。对Treg细胞水平失衡引发的自身免疫性疾病和Treg细胞水平失衡引发的免疫稳态失衡的辅助治疗。

著录项

  • 公开/公告号WO2018103723A1

    专利类型

  • 公开/公告日2018-06-14

    原文格式PDF

  • 申请/专利权人 GAO SHANGXIAN;

    申请/专利号WO2017CN115136

  • 发明设计人 GAO SHANGXIAN;

    申请日2017-12-08

  • 分类号A61K31/7004;A61P37/02;

  • 国家 WO

  • 入库时间 2022-08-21 12:43:50

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号